Publications by authors named "Ha Thai Pham"
NPJ Vaccines
November 2024
Article Synopsis
- - This phase 3 trial assessed the self-amplifying mRNA COVID-19 vaccine, ARCT-154, against the ChAdOx1-S adenovirus-vector vaccine in Vietnam, involving nearly 2,400 adult participants.
- - Both vaccines had similar safety profiles, with mainly mild-to-moderate side effects and few serious adverse events reported.
- - ARCT-154 showed higher neutralizing antibody responses and efficacy against COVID-19 compared to ChAdOx1-S, suggesting potential immunological advantages without compromising safety.
